NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00642577,A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.,https://clinicaltrials.gov/study/NCT00642577,,COMPLETED,"This 2 arm study will assess the efficacy and safety of Avastin in combination with irinotecan + 5-fluorouracil/folinic acid, versus irinotecan + fluorouracil/folinic acid alone, as first line treatment in Chinese patients with metastatic colorectal cancer. Patients will be randomized 2:1 to receive 6-weekly cycles of Avastin (5mg/kg iv every 2 weeks) + irinotecan 125mg/m2 iv / leucovorin 20mg/m2 iv / fluorouracil 500mg/m2 iv weekly for 4 weeks, or 6-weekly cycles of irinotecan 125mg/m2 iv / leucovorin 20mg/m2 iv / fluorouracil 500mg/m2 iv weekly for 4 weeks. The anticipated time on study treatment is until disease progression, and the sample size is 100-500 individuals.",NO,Colorectal Cancer,DRUG: bevacizumab [Avastin]|DRUG: irinotecan|DRUG: leucovorin|DRUG: fluorouracil,"Progression-free survival., 6 months","Overall response rate, time to response, duration of response, overall survival., Event driven|AEs, laboratory tests, Throughout study",,Hoffmann-La Roche,,ALL,"ADULT, OLDER_ADULT",PHASE3,214,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,BO20696,2007-07,2010-12,2010-12,2008-03-25,,2022-12-22,"Beijing, 100021, China|Beijing, 100036, China|Beijing, 100071, China|Chongqing, 400042, China|Guangdong, 510515, China|Guangzhou, 510060, China|Nanjing, 210002, China|Qingdao, 266003, China|Shanghai, 200003, China|Shanghai, 200080, China|Tianjin, 300060, China|Wuhan, 430030, China",
